Marijuana Co of America, Inc.
Healthcare · Medicinal Chemicals & Botanical Products · UT · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | |
|---|---|---|---|---|---|---|
| Revenue | $2.4M | $280,653 | $695,076 | $252,135 | $26,830 | $8,729 |
| Operating income | −$4.7M | −$4.9M | −$6.5M | −$3.8M | −$21.3M | −$4.7M |
| Net income | −$10.2M | −$12.1M | −$20.2M | −$11.1M | −$33.4M | −$5.4M |
| Total assets | $8.0M | $2.1M | $1.1M | $1.9M | $1.1M | $240,085 |
| Total liabilities | $7.7M | $7.6M | $11.7M | $5.1M | $11.4M | $369,886 |
| Equity | $230,889 | −$5.5M | −$10.6M | −$3.1M | −$10.3M | −$129,801 |
| EPS (diluted) | — | — | — | — | — | — |
| Shares out. | 4.84B | 241.5M | 2.69B | 2.56B | 2.10B | 1.62B |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2021- Operating margin
- −196.3%
- Net margin
- −424.6%
- Return on equity
- −4414.0%
- Return on assets
- −128.0%
- Return on capital (ROCE)
- −2040.4%
- Liabilities / assets
- 97.1%
- Debt / equity
- 33.48×
- Book value / share
- $0.00
- Revenue growth (YoY)
- 755.1%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2021- Altman Z″ (distress)
- -47.56distress
- Accruals / assets
- −78.0%clean
- Beneish M-Score
- 2.46elevated
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 5 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Beneish M-Score elevated — earnings-manipulation screen flag
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 15, 2023
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2023
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2022
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2022
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2022
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2021
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Quintero JesusOfficer — CEO, CFO | Nov 23, 2021 | Sell | 2.7M | $0.00 |
| Quintero JesusDirector | Sep 10, 2021 | Grant | 26.3M | $0.00 |
| Psomiadis ThemistoclesDirector | Jan 25, 2021 | Sell | 2.0M | $0.01 |
| Psomiadis ThemistoclesDirector | Jan 20, 2021 | Sell | 1.4M | $0.01 |
| Psomiadis ThemistoclesDirector | Dec 4, 2020 | D | 1.5M | $0.01 |
| Psomiadis ThemistoclesDirector | Nov 25, 2020 | Buy | 11.4M | $0.00 |
| Psomiadis ThemistoclesDirector | Oct 5, 2020 | Buy | 1.5M | $0.00 |
| Psomiadis ThemistoclesOfficer — Vice President | Sep 2, 2020 | Sell | 7.8M | $0.00 |
| Psomiadis ThemistoclesOfficer — Vice President | Aug 12, 2020 | Sell | 212,121 | $0.00 |
| Psomiadis ThemistoclesOfficer — Vice President | Jul 21, 2020 | Grant | 10.0M | $0.00 |
| Steinberg Donald J10% owner | Jun 8, 2020 | Sell | 220,879 | $0.01 |
| Steinberg Donald J10% owner | May 14, 2020 | Sell | 529,000 | $0.01 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Director / officer changeApr 4, 2023
- Changed auditorApr 4, 2023
- Director / officer changeFeb 8, 2023
- Other material eventDec 1, 2022
- Changed auditorNov 29, 2022
- Director / officer change · Shareholder voteSep 14, 2022
- Other material eventAug 29, 2022
- Other material eventAug 16, 2022
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12GCERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATIONJun 29, 2023
- NT 10-QNOTIFICATION OF LATE FILINGMay 15, 2023
- 8-KFORM 8-KApr 4, 2023
- 8-KFORM 8-KApr 4, 2023
- NT 10-KNOTIFICATION OF LATE FILINGMar 31, 2023
- 8-KFORM 8-KFeb 8, 2023
- DEF 14CDEFINITIVE 14CJan 3, 2023
- PRE 14CPRELIMINARY 14CDec 22, 2022
- 8-KFORM 8-KDec 1, 2022
- 8-KFORM 8-KNov 29, 2022
- 10-QFORM 10-QNov 21, 2022
- NT 10-QNOTIFICATION OF LATE FILINGNov 14, 2022
- QUALIFOct 11, 2022
- CORRESPOct 6, 2022
- UPLOADOct 6, 2022
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.